Alize Pharma III raised a round of funding on March 17, 2015.
Alize Pharma 3 develops therapeutic peptides for rare endocrine and metabolic diseases. Alize Pharma 3 is building a balanced portfolio of products targeting significant unmet medical needs. Its first…
